Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Published:2021-11-16 Issue:1 Volume:11 Page:86-93
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Shokoohi Aria¹^ORCID,Al‐Hashami Zamzam¹²,Moore Sara³,Pender Alexandra¹²,Wong Selina K.¹²,Wang Ying¹²,Leung Bonnie¹,Wu Jonn²⁴,Ho Cheryl¹²

Affiliation:

1. Department of Medical Oncology BC Cancer Vancouver British Columbia Canada

2. Faculty of Medicine University of British Columbia Vancouver British Columbia Canada

3. Division of Medical Oncology The Ottawa Hospital Ottawa Ontario Canada

4. Department of Radiation Oncology BC Cancer Vancouver British Columbia Canada

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4427

Reference21 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

3. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

4. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

5. Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study;Cancer Communications;2024-07-17

2. A non-small cell lung cancer patient experiencing venous thromboembolism during Osimertinib treatment, with disease recurrence and progression after therapy: a case report and literature review;2024-01-31

3. The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non–Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis;Value in Health;2023-12

4. Non-small cell lung cancer with bone metastasis and pneumocystis pneumonia in a pregnant woman: a case report and literature review;BMC Infectious Diseases;2023-11-14

5. Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG);Journal of Thoracic Oncology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3